![]() Sensei Biotherapeutics ( NASDAQ: SNSE) is an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer. Portfolio managers and analysts who would like to request a meeting with management should contact their representative at the respective hosting firms. ( NASDAQ: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer, today announced that Company management will participate in the following investor conferences in September 2022: 23, 2022 (GLOBE NEWSWIRE) - Sensei Biotherapeutics, Inc. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)Ĭalendars and Economy: 'Actual' numbers are added to the table after economic reports are released.BOSTON, Aug. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.Ĭryptocurrencies: Cryptocurrency quotes are updated in real-time. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Data may be intentionally delayed pursuant to supplier requirements. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Source: FactSetĭata are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Tullett PrebonĬommodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Tullett PrebonĬurrencies: Currency quotes are updated in real-time. Sources: FactSet, Dow Jonesīonds: Bond quotes are updated in real-time. Sources: FactSet, Dow JonesĮTF Movers: Includes ETFs & ETNs with volume of at least 50,000. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright © FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Ringo received an undergraduate degree and an MBA from the University of Dayton. and President & Chief Executive Officer of Abgenix, Inc. Ringo held the position of Independent Director at Sangamo Therapeutics, Inc., Chairman at Community Health Systems, Inc., Chairman of Health Systems, Inc., President-Infectious Diseases Business Unit at Eli Lilly & Co., Senior VP-Strategy & Business Development at Pfizer Inc., Strategic Advisor at Sofinnova Investments, Inc., Vice President-Sales & Marketing of US Pharmaceuticals, Inc., Non-Executive Chairman & Chief Executive Officer at InterMune, Inc., Chairman of Five Prime Therapeutics, Inc., Chairman for Hyperion Therapeutics, Inc. Ringo is also on the board of 5 other companies. and Venture Partner at InCube Venture Partners LLC. Ringo is Independent Non-Executive Chairman at Assembly Biosciences, Inc., Chairman for Sensei Biotherapeutics, Inc. Ringo is a businessperson who has been at the head of 9 different companies. Ringo Chairman, Sensei Biotherapeutics, Inc.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |